CASMED Reports Preliminary Net Sales for the 2018 Fourth

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
30
CASMED Reports Preliminary Net Sales for the 2018 Fourth Quarter and Full Year

Record Q4 FORE-SIGHT® cerebral oximetry sales drive 18% full-year FORE-SIGHT sales growth

Introduces 2019 FORE-SIGHT sales guidance

BRANFORD, Conn., Jan. 03, 2019 (GLOBE NEWSWIRE) -- CAS Medical Systems, Inc. (NASDAQ: CASM) (CASMED), a leader in non-invasive cerebral oximetry patient monitoring, reports preliminary unaudited topline results for the three and 12 months ended December 31, 2018.

The Company expects net sales from continuing operations for the fourth quarter of 2018 to be approximately $5.8 million, up 13% from $5.1 million for the fourth quarter of 2017.  Net sales from continuing operations for 2018 are expected to be approximately $21.9 million, up 17% from $18.8 million for 2017.

FORE-SIGHT highlights for the 2018 fourth quarter and full year compared with the respective prior-year periods are expected to include the following:

  • FORE-SIGHT disposable sensor sales increased 20% for the fourth quarter, driven by a 50% increase in international sensor sales and a 16% increase in domestic sensor sales.
  • For the fourth quarter, FORE-SIGHT cerebral oximetry sales in the U.S. increased 10% to approximately $4.7 million and increased 38% internationally to approximately $1.0 million.
  • For the full year, FORE-SIGHT cerebral oximetry sales increased 18% to approximately $21.4 million, driven by an 18% increase in disposable sensor sales and 18% growth in monitor/accessories sales.
  • During the fourth quarter, a net 108 FORE-SIGHT cerebral oximeters were shipped to new and existing customers worldwide, with a net 60 monitors shipped in the U.S.
  • The adjusted installed base of U.S. monitors grew to 1,458 as of December 31, 2018, up 17% from 1,245 monitors as of December 31, 2017. 
  • The Company’s year-end cash balance plus cash available under its line of credit was approximately $5.2 million.

“I’m pleased to report record FORE-SIGHT oximetry sales for the fourth quarter, with strong growth coming from the U.S. and international markets and our fifth consecutive quarter of year-over-year double-digit FORE-SIGHT sales increases,” said Thomas M. Patton, President and Chief Executive Officer of CASMED.  “FORE-SIGHT disposable sensor sales for the quarter grew 20% and represented 90% of total sales.  We attribute this growth primarily to strong execution by our maturing domestic salesforce and growth from key international distributors as we expand the market for our FORE-SIGHT products worldwide. 

“It was gratifying to ship our first production of FORE-SIGHT OEM smart cables to our corporate partner in late-December,” he added.  “Given our progress, we are on track to commercially launch our FORE-SIGHT OEM smart cables in mid-2019.   

“Excluding potential OEM smart cable sales, for 2019 we expect low-teens percentage growth in U.S. FORE-SIGHT sales, driven by mid-teens percentage growth in U.S. disposable sensor sales, as we continue to take market share from competitors and expand the market for cerebral and tissue oximetry monitoring.  We expect international FORE-SIGHT sales to increase in the high single-digit percentages.  Therefore, before OEM sales, we expect low double-digit total FORE-SIGHT sales growth for the year.  We plan to update our 2019 outlook in mid-2019 to include the contribution from OEM smart cables,” Patton concluded.

CASMED expects to report financial results for the 2018 fourth quarter and full year, and to hold an investment-community conference call in early March 2019.

About CASMED ® – Monitoring What's Vital

CASMED’s vision is:  “That no patient is harmed by undetected tissue hypoxia.”  Our FORE-SIGHT® Cerebral Oximeters provide a highly accurate, non-invasive measurement of tissue oxygenation in the brain.  Direct monitoring of tissue oxygenation can provide clinicians with a superior and powerful tool to alert them to otherwise unrecognized and dangerous hypoxia, or low levels of oxygen, in the brain and other tissue, thereby empowering them to improve patient care.  For further information regarding CASMED, visit the Company's website at www.casmed.com .

Statements included in this press release, which are not historical in nature, are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Statements relating to the future performance of the Company are subject to many factors including, but not limited to, customer acceptance of the products in the market, the introduction of competitive products and product development, the impact of any product liability or other adverse litigation, working capital and availability of capital, commercialization and technological difficulties , the impact of actions and events involving key customers, vendors, lenders, competitors, and other risks detailed in the Company’s Form 10-K for the year ended December 31, 2017, and other subsequent Securities and Exchange Commission filings.

Such statements are based upon the current beliefs and expectations of the Company’s management and are subject to significant risks and uncertainties. Actual results may differ from those set forth in the forward-looking statements. When used in this press release, the terms "anticipate", "believe", "estimate", "expect", "may", "objective", "plan", "possible", "potential", "project", "will", and similar expressions identify forward-looking statements. The forward-looking statements contained in this press release are made as of the date hereof, and we do not undertake any obligation to update any forward-looking statements, whether as a result of future events, new information, or otherwise.

Company Contact CAS Medical Systems, Inc. Jeffery A. Baird Chief Financial Officer (203) 315-6303 ir@casmed.com   Investors LHA Investor Relations Bruce Voss / Jody Cain (310) 691-7100 bvoss@lhai.com jcain@lhai.com    
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sports Leagues Confront Youth Gambling's Hard Truth

Updated Category News Views 35

A stadium-sized advertising machine cannot pretend kids are not watching. That is the uncomfortable backdrop to the National Council on Problem Gambling's November 10 youth gambling prevention summit, where representatives from the NFL, MLB, NBA and PGA Tour met at the NFL's New York offices. Good that they showed up. Frankly, with gambling stitched into so much sports...

Continue Reading
Anduin Opens Its Investor Portal Beyond Early Users

Updated Category News Views 68

Private-market paperwork has long been a swamp of portals, PDFs, email chains, and somebody chasing down a wire change at the worst possible moment. Anduin is taking a swing at that mess by opening its Investor Portal to all customers after building it with leading asset managers and operating it with their investors. The pitch is sensible: give limited partners one...

Continue Reading
Trip.Best Expands Global Travel Discovery Footprint

Updated Category News Views 123

Sydney just became the map pin for a fairly serious travel-content land grab. Trip.Best, Trip.com Group's ranking brand, has rolled out its 2027 Annual Rankings with coverage of all seven continents for the first time. This is not an earnings release, and nobody should pretend a hotel list magically turns into revenue by lunchtime. Still, the jump from 85 to 98 annual...

Continue Reading
Morrison Tests Abu Dhabi as Its Next Capital Hub

Updated Category News Views 60

Abu Dhabi keeps collecting infrastructure managers the way a strong port collects ships: because the money, the policy ambition, and the projects are all converging there. Morrison’s decision to establish an office in ADGM is not some chest-thumping headline about instant deal flow. It is a practical move by a firm with nearly four decades behind it and more than US$35...

Continue Reading
Saturn and Tileward Put GPU Memory Back to Work Now

Updated Category News Views 49

GPU memory is the tollbooth nobody notices until the whole AI highway backs up. Saturn Cloud’s new partnership with Tileward goes straight at that constraint: use compressed open-model weights, free memory on hardware already installed, and turn that reclaimed capacity into more tokens that an operator can actually sell. It is not glamorous. It may be one of the more...

Continue Reading
TCL CSOT's Oxide Leap Gives LCD a Sharper Fight Ahead

Updated Category News Views 64

Fifty-one point six is the number that makes this announcement worth chewing on. TCL CSOT says it has moved ultrahigh-mobility oxide technology into mass production on an 8.6-generation line, clearing the 50 cm² V?¹ s?¹ threshold that has largely belonged to lab-talk and presentation slides. For display people, that is not decorative science. It could change the old...

Continue Reading
Huhtamaki Maps Its 2027 Reporting Dates for Investors

Updated Category News Views 96

A calendar release rarely makes the pulse race, but it tells shareholders when the curtain will actually go up. Huhtamäki Oyj has laid out its 2027 financial reporting timetable, and the useful part is its plainness: investors now know the handful of dates when management will have to put numbers, not broad ambitions, in front of the market. For a packaging company, that...

Continue Reading
Prospera’s DFW Culture Win Matters Beyond the Plaque

Updated Category News Views 46

Employee survey ballots rarely make pulses race, but this one deserves more than a lazy shrug. Prospera Financial Services has landed on The Dallas Morning News’ 2026 Top Workplaces DFW list for a second consecutive year, placing in the Top Small Workplaces category. For a boutique independent broker-dealer, that is not meaningless wall décor. The people doing the...

Continue Reading
Teva’s R&D Exit Puts Disclosure Questions in Focus

Updated Category News Views 33

An abrupt departure in the drug business is never just an HR memo. Teva Pharmaceutical Industries shares reportedly dropped about 8.74% after Eric Hughes, the company’s executive vice president of Global R&D and chief medical officer, left effective immediately. That kind of move rattles investors because R&D leadership is not decorative furniture at a pharmaceutical...

Continue Reading
New York Gala Puts $3 Million Behind EB Research Work

Updated Category News Views 54

Three million dollars changes the temperature in a research room, even if it does not magically solve the hard part. EB Research Partnership said its New York gala raised more than $3 million, with Eddie Vedder, Hozier, Tom Holland and Colin Farrell among the names helping draw attention. For a nonprofit operating around research, that is not a fluffy society-page...

Continue Reading

Top 5 Most Recently Viewed Articles

Winter Weather in California: Safeguarding Your Home's Integrity

Updated Category News Views 107

California's Winter Weather: A Wake-Up Call for Homeowners As California braces for a challenging winter season characterized by heavy rains and potential flash floods, homeowners must recognize the structural risks to their properties. Alpha Structural, Inc. emphasizes the importance of proactive measures to safeguard homes against these weather-related threats....

Continue Reading
WELL Health Advances with Expanding Clinics and Public Sector Growth

Updated Category News Views 322

WELL Health's Growing Clinics and Services WELL Health Technologies Corp. is making significant strides in the Canadian healthcare landscape. Recently, the company reported expanding its network by adding 11 new clinics, a move that reflects its commitment to enhancing healthcare access and quality across the country. This new addition comprises 9 clinics acquired and 2...

Continue Reading
Growth Surge in Australia's Construction Market Expected Until 2029

Updated Category News Views 162

Overview of Australia's Construction Market Growth The Australian construction landscape is poised for a significant transformation, anticipating a remarkable growth spurt of USD 42.1 billion from 2025 to 2029. As urban migration steadily rises, the demand for diverse construction projects, encompassing both residential and commercial sectors, is increasingly pronounced....

Continue Reading
Market Insights: Indonesian Stocks Encounter Declines Today

Updated Category News Views 251

Market Overview: Indonesian Stocks on the Decline Today’s trading session in Indonesia witnessed a downward trend, as the stock market closed with losses influenced primarily by the Financials, Agriculture, and Basic Industry sectors. This decline reflects broader market sentiments and economic factors affecting investor decisions. IDX Composite Index Performance The...

Continue Reading
Dowlais Group plc and Recent Share Dealings Analysis

Updated Category News Views 193

Understanding Recent Dealings In Dowlais Group Plc Investors have been keenly observing the movements and transactions of Dowlais Group Plc, particularly as the company continues to navigate the complexities of the market. A significant reporting came in the form of disclosures related to share purchases and sales, which are vital for understanding the company's financial...

Continue Reading